ProShare Advisors
ANGO icon

ProShare Advisors’s AngioDynamics ANGO Stock Holding History

ProShare Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,899
Closed -$99.8K – 2095
2024
Q4 		$99.8K Buy
+10,899
New +$80.1K ﹤0.01% 2075
2022
Q1 		– Sell
-9,403
Closed -$259K – 2206
2021
Q4 		$259K Buy
+9,403
New +$259K ﹤0.01% 1876
2021
Q3 		– Sell
-10,637
Closed -$289K – 2018
2021
Q2 		$289K Sell
10,637
-287
-3% -$7.01K ﹤0.01% 1919
2021
Q1 		$256K Buy
+10,924
New +$221K ﹤0.01% 1890
2014
Q3 		– Sell
-11,894
Closed -$194K – 2297
2014
Q2 		$194K Sell
11,894
-13,018
-52% -$188K ﹤0.01% 2185
2014
Q1 		$392K Buy
+24,912
New +$406K ﹤0.01% 2048
2013
Q4 		– Sell
-15,643
Closed -$206K – 1365
2013
Q3 		$206K Sell
15,643
-197
-1% -$2.32K ﹤0.01% 2171
2013
Q2 		$179K Buy
+15,840
New +$169K ﹤0.01% 2077

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ProShare Advisors's ANGO Position: Q1 2025 in Review

ProShare Advisors sold out of AngioDynamics (ANGO) in Q1 2025, closing a stake of 10,899 shares — an estimated $99.8K sold.

ProShare Advisors first reported a position in ANGO in Q2 2013 and held it in 8 quarters. The position peaked at $392K in Q1 2014. 154 funds tracked by Wall St. Rank hold ANGO as of Q1 2025.

  • ProShare Advisors reported no remaining AngioDynamics position as of Q1 2025 after selling out during the quarter.
  • ProShare Advisors sold 10,899 AngioDynamics shares in Q1 2025, an estimated $99.8K.
  • ProShare Advisors first reported a position in AngioDynamics in Q2 2013 and held it in 8 quarters.
  • ProShare Advisors's AngioDynamics position peaked at $392K in Q1 2014.
  • 154 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2025.

Based on ProShare Advisors's 13F filing for Q1 2025, filed 8 May 2025.